Conflict-Driven Rerouting Threatens Global Cancer Drug Supply Chains
Ongoing geopolitical conflict has forced a massive rerouting of pharmaceutical shipments, creating significant delays in the delivery of life-saving cancer treatments. Logistics providers are struggling with increased costs and cold-chain integrity risks as traditional transit corridors become inaccessible.